Anlotinib Inhibits Tumor Angiogenesis and Promotes the Anticancer Effect of Radiotherapy on Esophageal Cancer through Inhibiting EphA2.

Zhenlin Gu,Weiguo Zhu,Wanwei Wang,Yingying Xu,Lei Jiang,Jiasheng Huang,Jing Huang

Journal of oncology（2022）

引用 0|浏览7

暂无评分

摘要

It is concluded that anlotinib inhibits EphA2 expression, thereby suppressing angiogenesis and resensitizing EC cells to radiotherapy, providing another perspective to overcome radioresistance in EC.

查看译文

关键词

anlotinib inhibits tumor angiogenesis,anticancer effect,esophageal anticancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要